PHEON THERAPEUTICS LTD

Active Sandwich

Research and experimental development on biotechnology

11 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
P

PHEON THERAPEUTICS LTD

Research and experimental development on biotechnology

Founded 8 Jul 2015 Active Sandwich, United Kingdom 11 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

FEMTOGENIX LTD 8 Jul 2015 — 3 Aug 2022
Accounts Submitted 30 Oct 2025 Next due 31 Dec 2026 8 months remaining
Confirmation Submitted 30 Oct 2025 Next due 2 Nov 2026 6 months remaining
Net assets £36M £19M 2024 year on year
Total assets £42M £23M 2024 year on year
Total Liabilities £5M £4M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Innovation House Innovation Way Discovery Park Sandwich Kent CT13 9FF United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for PHEON THERAPEUTICS LTD (09677410), an active life sciences and medical technology company based in Sandwich, United Kingdom. Incorporated 8 Jul 2015. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2016–2024)

Cash in Bank

£37.68M

Increased by £20.91M (+125%)

Net Assets

£36.36M

Increased by £18.89M (+108%)

Total Liabilities

£5.36M

Increased by £3.74M (+232%)

Turnover

N/A

Employees

11

Increased by 2 (+22%)

Debt Ratio

13%

Increased by 5 (+63%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 4

Investors (8)

Investor NameInvestor SinceParticipating Rounds
Investor 1Sept 2022Series A, Series B
Investor 2Sept 2022Series A, Series B
Investor 3Sept 2022Series A, Series B

Share Capital

Share Capital

Share allotments and capital structure

66 Allotments 59,530,953 Shares £120.63m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
15 Oct 20252,036,437£4.68m£2.299
15 Oct 20251,225,490£2.82m£2.299
15 Oct 20252,506,036£5.76m£2.299
15 Oct 202523,617£2.299£2.299
15 Oct 20254,084,967£9.39m£2.299

Officers

Officers

2 active 1 resigned
Status
Jeffery AlbersDirectorAmericanUnited States541 Jan 2023Active
Jonathan Leslie TobinDirectorBritishUnited Kingdom4314 Mar 2022Active

Shareholders

Shareholders (54)

Tcg Crossover Fund Ii, L.p
10.7%
8,169,934
Atlas Venture Fund Xii, L.p
10.4%
7,909,320

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
30 Oct 2025Confirmation StatementConfirmation statement made on 2025-10-19 with updates
30 Oct 2025AccountsAnnual accounts made up to 2025-03-31
30 Oct 2025CapitalAllotment of shares (GBP 7,608.9809) on 2025-10-15
11 Aug 2025OfficersAppointment of Mr Samuel Blackman as director on 2025-06-30
2 May 2025CapitalAllotment of shares (GBP 5,648.1976) on 2025-02-12
30 Oct 2025 Confirmation Statement

Confirmation statement made on 2025-10-19 with updates

30 Oct 2025 Accounts

Annual accounts made up to 2025-03-31

30 Oct 2025 Capital

Allotment of shares (GBP 7,608.9809) on 2025-10-15

11 Aug 2025 Officers

Appointment of Mr Samuel Blackman as director on 2025-06-30

2 May 2025 Capital

Allotment of shares (GBP 5,648.1976) on 2025-02-12

Recent Activity

Latest Activity

Confirmation statement made on 2025-10-19 with updates

5 months ago on 30 Oct 2025

Annual accounts made up to 2025-03-31

5 months ago on 30 Oct 2025

Allotment of shares (GBP 7,608.9809) on 2025-10-15

5 months ago on 30 Oct 2025

Appointment of Mr Samuel Blackman as director on 2025-06-30

8 months ago on 11 Aug 2025

Allotment of shares (GBP 5,648.1976) on 2025-02-12

11 months ago on 2 May 2025